Chrono Therapeutics

📍 Hayward, United States🗓 Founded 2004👥 18 employees💰 Last funded Jan 2016
Pharmaceuticals🌐 chronothera.com
Website LinkedIn
Chrono Therapeutics is focused on improving clinical outcomes for patients battling addictions and living with neurological disorders via our proprietary Digital Patch platform, pioneering a new era of transdermal drug delivery designed to meet each patient's individual needs. By integrating timed drug delivery with personalized, mobile-phone-based digital support and unique data analytics to maximize compliance, we help patients manage hard to treat conditions and optimize clinical outcomes. We have multiple programs in active development that address significant market opportunities with unmet (or poorly) met needs. Each of our programs leverages medications that readily cross the skin. In addition to the programs currently in development for smoking cessation, Parkinson's Disease dyskinesia and prescription opioid dependence, our discovery pipeline is robust, with a number of CNS indications under evaluation that would benefit from a therapeutic combined with behavioral and compliance support.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
2004
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2014–2016 · investors recorded per year
2014320161
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Chrono Therapeutics?
Chrono Therapeutics has 4 investors on record on gritt.io.
When did Chrono Therapeutics last raise funding?
The most recent investment in Chrono Therapeutics recorded on gritt.io was in January 2016.
When was Chrono Therapeutics founded?
Chrono Therapeutics was founded in 2004.
What industry is Chrono Therapeutics in?
Chrono Therapeutics operates in Pharmaceuticals. Find similar Pharmaceuticals investors on gritt.io.
Where is Chrono Therapeutics based?
Chrono Therapeutics is headquartered in Hayward, United States.